Sartan issues continue as Macleods and Camber issue recalls
Camber and Macleods voluntarily recall losartan tablets lots, after trace amounts of a possible carcinogen found in an API ingredient manufactured at the same third-party facility.
Archives for March 4, 2019
TrialAssure debuts clinical data anonymization software
TrialAssure releases anonymizing SaaS to enable sponsors to share clinical trial data, as the industry shifts towards utilizing big data while maintaining patient privacy.
Novartis joins longitudinal study for RWD
Novartis Pharma AG partners with Target PharmaSolutions to support its global longitudinal observational study designed to generate real-world clinical data.
Who Needs to Comply With the Revised Common Rule and What Does It Mean for Informed Consent Forms?
Paid for and content provided by Advarra
Most requirements for the revised Common Rule are in effect. This article serves as a guide for researchers who are still unsure if they need to comply or what that means when it comes to informed consent form (ICF) requirements.